Recently, it has been found that when MSFT has telomerase reverse transcriptase gene (TERT) promoter mutations, TP53 gene mutations, and APAF1 gene mutations, the tumor is more aggressive, with a relatively high risk of metastasis and a relatively poorer prognosis (49). This evidence concerns the gene TERT and neoplasm.